Biohaven Ltd.
BHVN
$15.00
$0.281.90%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -586.84M | -647.68M | -738.82M | -780.11M | -766.97M |
| Total Depreciation and Amortization | 10.32M | 10.04M | 9.92M | 9.81M | 8.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 114.36M | 90.75M | 118.11M | 115.62M | 84.52M |
| Change in Net Operating Assets | -49.24M | -47.35M | 1.36M | 5.17M | 28.70M |
| Cash from Operations | -511.40M | -594.23M | -609.44M | -649.52M | -645.08M |
| Capital Expenditure | -475.00K | -254.00K | -715.00K | -756.00K | -1.35M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 391.00K | 391.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 211.74M | 151.15M | 301.28M | 226.99M | -30.78M |
| Cash from Investing | 211.26M | 150.89M | 300.56M | 226.62M | -31.74M |
| Total Debt Issued | 0.00 | 250.00M | 250.00M | 250.00M | 250.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 372.37M | 369.66M | 191.01M | 275.77M | 356.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -644.00K | -1.89M | -1.89M | -2.60M | -2.60M |
| Cash from Financing | 371.73M | 617.76M | 439.12M | 523.17M | 603.43M |
| Foreign Exchange rate Adjustments | 33.00K | -10.00K | -3.00K | 85.00K | 71.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.63M | 174.42M | 130.24M | 100.37M | -73.32M |